Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer DiseaseStephen Salloway, Karen Smirnakis, Jerome Barakos et al.|JAMA Neurology|2021Cited by 590
Updated safety results from phase 3 lecanemab study in early Alzheimer’s diseaseLawrence S. Honig, Lynn D. Kramer, Marwan N. Sabbagh et al.|Alzheimer s Research & Therapy|2024Cited by 150